RECRUITINGOBSERVATIONAL
Genetic Study of Amyotrophic Lateral Sclerosis in Norway
Genetisk Studie av Amyotrofisk Lateral Sklerose (ALS)
About This Trial
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.
Who May Be Eligible (Plain English)
Who May Qualify:
- Probable or definite ALS
- Eligible to consent
Who Should NOT Join This Trial:
\- not competent to give consent
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Probable or definite ALS
* Eligible to consent
Exclusion Criteria:
\- not competent to give consent
Treatments Being Tested
OTHER
Observation
Observation of genetic characteristics
Locations (17)
Haukeland University Hospital, Department of Neurology
Bergen, Norway
Nordland Hospital Trust, Department of Neurology
Bodø, Norway
Vestre Viken Hospital Trust, Department of Neurology
Drammen, Norway
Førde Hospital Trust, Department of Neurology
Førde, Norway
Østfold Hospital Trust, Department of Neurology
Grålum, Norway
Fonna Hospital Trust, Department of Neurology
Haugesund, Norway
Sørlandet Hospital Trust, Department of Neurology
Kristiansand, Norway
Innlandet Hospital Trust, Department of Neurology
Lillehammer, Norway
Akershus University Hospital, Department of Neurology
Lørenskog, Norway
Møre and Romsdal Hospital Trust, Department of Neurology
Molde, Norway
Nord-Trøndelag Hospital Trust, Department of Neurology
Namsos, Norway
Oslo University Hospital, Department of Neurology
Oslo, Norway
Telemark Hospital, Department of Neurology
Skien, Norway
Stavanger University Hospital, Department of Neurology
Stavanger, Norway
University hospital of North Norway, Department of Neurology
Tromsø, Norway
St. Olavs Hospital, Department of Neurology
Trondheim, Norway
Vestfold Hospital Trust, Department of Neurology
Tønsberg, Norway